The platform Cabs (Custom Antibody Service), recently launched, provides universities, public and private research organizations with solutions for antigen detection. CAbS produces monoclonal and polyclonal antibodies for proteins, peptides, organic molecules or other antigens, through standard or customized protocols.

 

The CAbS facilities.Antibodies have a wide range of applications in industry and research. Their ability to recognize different molecules has been exploited in diverse areas. Thus in the biomedical field, antibodies have found application for diagnostic and therapeutic applications. Similarly in other areas such as food safety, agriculture or the environmental field.

In CAbS, each project is treated confidentially and is planned according to the custom needs, paying special attention to the immunogen used since their appropriate design is essential to modulate the selectivity and affinity of the antibodies produced.

The CAbS platform is one of the few laboratories that provides support and advice to produce antibodies for low molecular weight molecules such as pharmaceuticals, pesticides, or any other chemical.

CAbS is a joint facility of the CIBER-BBN (Networking Research Center for Biomaterials, Bioengineering and Nanomedicine) and CSIC (Spanish Council for Scientific Research), established at the Institute of Advanced Chemistry in Catalonia (IQAC-CSIC).

More information can be reached through the web page http://www.iiqab.csic.es/amrg and the e-mail address This email address is being protected from spambots. You need JavaScript enabled to view it.